comparative efficacy and safety

comparative efficacy and safety

7 Obesity Treatment Secrets Drains Your Wallet

Tirzepatide costs about 17% more per year than semaglutide for non-diabetic obesity patients, and the price gap widens when administration fees and real-world injection needs are considered. In my experience, the financial side of weight-loss therapy is as critical as the clinical side, especially for patients managing high deductibles. Medical